These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 15073770

  • 1. Patterns of use of pancreatic enzyme supplements in fibrosing colonopathy: implications for pathogenesis.
    Bakowski MT, Prescott P.
    Pharmacoepidemiol Drug Saf; 1997 Sep; 6(5):347-58. PubMed ID: 15073770
    [Abstract] [Full Text] [Related]

  • 2. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis.
    FitzSimmons SC, Burkhart GA, Borowitz D, Grand RJ, Hammerstrom T, Durie PR, Lloyd-Still JD, Lowenfels AB.
    N Engl J Med; 1997 May 01; 336(18):1283-9. PubMed ID: 9113931
    [Abstract] [Full Text] [Related]

  • 3. Comparative and experimental pathology of fibrosing colonopathy.
    van Velzen D, Ball LM, Dezfulian AR, Southgate A, Howard CV.
    Postgrad Med J; 1996 Mar 01; 72 Suppl 2():S39-48; discussion S49-51. PubMed ID: 8869182
    [Abstract] [Full Text] [Related]

  • 4. Pathogenesis of fibrosing colonopathy: the role of methacrylic acid copolymer.
    Prescott P, Bakowski MT.
    Pharmacoepidemiol Drug Saf; 1999 Oct 01; 8(6):377-84. PubMed ID: 15073899
    [Abstract] [Full Text] [Related]

  • 5. Direct assessment of gastrointestinal inflammation and mucosal immunity in children with cystic fibrosis.
    Croft NM, Marshall TG, Ferguson A.
    Postgrad Med J; 1996 Mar 01; 72 Suppl 2():S32-6. PubMed ID: 8869180
    [Abstract] [Full Text] [Related]

  • 6. Pancreatic enzyme supplementation in cystic fibrosis patients before and after fibrosing colonopathy.
    Stevens JC, Maguiness KM, Hollingsworth J, Heilman DK, Chong SK.
    J Pediatr Gastroenterol Nutr; 1998 Jan 01; 26(1):80-4. PubMed ID: 9443125
    [Abstract] [Full Text] [Related]

  • 7. Fibrosing colonopathy in cystic fibrosis: results of a case-control study.
    Smyth RL, Ashby D, O'Hea U, Burrows E, Lewis P, van Velzen D, Dodge JA.
    Lancet; 1995 Nov 11; 346(8985):1247-51. PubMed ID: 7475715
    [Abstract] [Full Text] [Related]

  • 8. Fibrosing colonopathy in an adult cystic fibrosis patient after discontinuing pancreatic enzyme therapy.
    Mack EH, Brett AS, Brown D.
    South Med J; 2004 Sep 11; 97(9):901-4. PubMed ID: 15455984
    [Abstract] [Full Text] [Related]

  • 9. Diagnosis and treatment of intestinal malabsorption in cystic fibrosis.
    Littlewood JM, Wolfe SP, Conway SP.
    Pediatr Pulmonol; 2006 Jan 11; 41(1):35-49. PubMed ID: 16288483
    [Abstract] [Full Text] [Related]

  • 10. Fibrosing Colonopathy Presenting in a Patient with Cystinosis.
    Fiore D, Sohini V, Mileti E, Fiore N.
    JPGN Rep; 2023 Aug 11; 4(3):e321. PubMed ID: 37600607
    [Abstract] [Full Text] [Related]

  • 11. Cystic fibrosis with fibrosing colonopathy in the absence of pancreatic enzymes.
    Waters BL.
    Pediatr Dev Pathol; 1998 Aug 11; 1(1):74-8. PubMed ID: 10463274
    [Abstract] [Full Text] [Related]

  • 12. Fibrosing colonopathy in cystic fibrosis.
    Smyth RL.
    Arch Dis Child; 1996 May 11; 74(5):464-8. PubMed ID: 8669970
    [Abstract] [Full Text] [Related]

  • 13. Is fibrosing colonopathy an immune mediated disease?
    Lee J, Ip W, Durie P.
    Arch Dis Child; 1997 Jul 11; 77(1):66-70. PubMed ID: 9279159
    [Abstract] [Full Text] [Related]

  • 14. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM, Rhodes P, Connelly BL, Bi D, Hahn C, Patrick S, Glodé MP, Ehresmann KR, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. kbisgard@cdc.gov.
    Pediatrics; 2005 Aug 11; 116(2):e285-94. PubMed ID: 16061582
    [Abstract] [Full Text] [Related]

  • 15. Cystic fibrosis-associated colitis and fibrosing colonopathy.
    Schwarzenberg SJ, Wielinski CL, Shamieh I, Carpenter BL, Jessurun J, Weisdorf SA, Warwick WJ, Sharp HL.
    J Pediatr; 1995 Oct 11; 127(4):565-70. PubMed ID: 7562277
    [Abstract] [Full Text] [Related]

  • 16. Incidence of fibrosing colonopathy with pancreatic enzyme replacement therapy in patients with cystic fibrosis.
    Chiuve SE, Fife D, Leitz G, Peterson C, Campbell NM, Rennig A, Rodrigues L, Decktor D, Dowd C, Marshall BC, Borowitz D.
    J Cyst Fibros; 2023 Nov 11; 22(6):1017-1023. PubMed ID: 37880023
    [Abstract] [Full Text] [Related]

  • 17. First adult patient with fibrosing colonopathy.
    Häusler M, Meilicke R, Biesterfeld S, Heimann G.
    Am J Gastroenterol; 1998 Jul 11; 93(7):1171-2. PubMed ID: 9672356
    [Abstract] [Full Text] [Related]

  • 18. Ultrase MT12 and Ultrase MT20 in the treatment of exocrine pancreatic insufficiency in cystic fibrosis: safety and efficacy.
    Konstan MW, Stern RC, Trout JR, Sherman JM, Eigen H, Wagener JS, Duggan C, Wohl ME, Colin P.
    Aliment Pharmacol Ther; 2004 Dec 11; 20(11-12):1365-71. PubMed ID: 15606399
    [Abstract] [Full Text] [Related]

  • 19. Fibrosing colonopathy in an adult owing to over use of pancreatic enzyme supplements.
    Bansi DS, Price A, Russell C, Sarner M.
    Gut; 2000 Feb 11; 46(2):283-5. PubMed ID: 10644326
    [Abstract] [Full Text] [Related]

  • 20. Fibrosing colonopathy in a man with cystic fibrosis on pancreatic enzyme supplements.
    Jain S, Subramony C, Blanchard K, Petro M, Minocha A.
    Indian J Gastroenterol; 2005 Feb 11; 24(6):238. PubMed ID: 16424618
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.